Allspring Global Investments Holdings, LLC Rallybio Corp Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 18, 2023
BUY
$4.31 - $8.89 $2,004 - $4,133
465 New
465 $2,000
Q4 2022

Jan 23, 2023
SELL
$4.67 - $14.86 $102 - $326
-22 Reduced 2.14%
1,006 $6.61 Million
Q3 2022

Oct 26, 2022
BUY
$7.54 - $14.56 $7,751 - $14,967
1,028 New
1,028 $14,000
Q2 2022

Jul 25, 2022
SELL
$6.26 - $13.65 $27,850 - $60,728
-4,449 Closed
0 $0
Q1 2022

May 02, 2022
BUY
$6.91 - $15.04 $10,606 - $23,086
1,535 Added 52.68%
4,449 $31,000
Q4 2021

Jan 28, 2022
BUY
$9.3 - $19.91 $27,100 - $58,017
2,914 New
2,914 $27,000

Others Institutions Holding RLYB

# of Institutions
52
Shares Held
31.9M
Call Options Held
0
Put Options Held
0
View Full List

About Rallybio Corp

RLYB Quotes by TradingView
  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $30.5M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email